The cervical cancer vaccine, Cervavac, is a Quadrivalent Human Papillomavirus vaccine (qHPV)developed by the Serum Institute of India (SII) and the Department of Biotechnology (DBT).
The World Health Organisation has launched a USD 1.5 billion campaign, including a new vaccine, to eliminate outbreaks of bacterial meningitis across Africa by 2030.
EXAMIANS